IP Verse

Pfiz patent opposition analysis

The comprehensive analysis of Pfiz opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Pfiz

Stay updated with the latest patent oppositions filed by Pfiz

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4051265
Functionalized Peptides As Antiviral AgentsENANTA PHARMACEUTICALSMay 6, 2026PFIZER
EP3527224
Rsv Immunization RegimenGLAXOSMITHKLINENov 26, 2025PFIZER
EP4144368
Rsv Immunization RegimenGLAXOSMITHKLINENov 26, 2025PFIZER
EP3595727
Lipid Nanoparticle FormulationMODERNAAug 26, 2025PFIZER
EP4108671
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAAug 20, 2025PFIZER
EP3981437
Nucleic Acid VaccinesMODERNAJul 4, 2025PFIZER
EP4023249
Nucleic Acid VaccinesMODERNAJul 4, 2025PFIZER
EP4032979
Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionUNIQURE BIOPHARMAJan 31, 2025PFIZER
EP3596123
Fc-Optimized Anti-Cd25 For Tumour Specific Cell DepletionTUSK THERAPEUTICSOct 4, 2024PFIZER
EP3513802
Vector For Liver-Directed Gene Therapy Of Hemophilia And Methods And Use ThereofVRIJE UNIVERSITEIT BRUSSELAug 27, 2024PFIZER

Top clients of Pfiz

Top companies who are the clients of Pfiz

CompanyTotal
PFIZER36
PUTZMEISTER ENGINEERING3
DRR SYSTEMS2
DURR SYSTEMS1
DURR CYPLAN1
DURR CTS1
DRR1